How reliable is blood group testing (ABO and Rh) in a newborn infant?

Blood Group Testing Reliability in Newborns

Blood group (ABO and Rh) antigen testing in newborns is highly reliable and accurate, but reverse typing (antibody detection) is unreliable due to immature antibody production in infants under 6 months of age.

Key Testing Principles

Antigen Detection (Forward Typing)

• ABO and RhD antigen detection is accurate and reliable in newborns from birth, as red blood cell antigens are well-developed by 6 weeks of gestation and fully expressed at birth 1, 2
• Both automated microcolumn gel methods and traditional tube methods show equivalent accuracy for antigen detection with no significant differences in agglutination intensity 3
• RhD antigen can be detected as early as 38 days of fetal life 4

Antibody Detection (Reverse Typing)

This is where reliability becomes problematic:

• Reverse typing (detecting anti-A or anti-B antibodies) is unreliable in infants under 6 months due to immature immune system and insufficient antibody production 3, 5
• Detection rates and agglutination intensity of ABO antibodies are significantly lower in:
  • Preterm infants compared to term infants
  • Infants under 3 months compared to those 4-6 months old 3
• Only 19.3% of type A and B infants and 7% of AB infants showed detectable immune antibodies in cord blood 6

Clinical Implications

For Blood Transfusion Decisions

When forward and reverse typing results are concordant in infants, transfuse with ABO-identical blood. However, when results are discordant (which is common):

• Use washed O-negative red blood cells for transfusion 5
• Perform PCR-SSP genotyping for definitive blood group determination if needed 5
• Transition to ABO-identical transfusions once genotyping confirms blood type

For Hemolytic Disease Screening

• Direct antiglobulin test (DAT/Coombs) at birth is recommended for detecting maternal antibodies on neonatal red cells 7
• DAT positivity occurs in approximately 2.7% of newborns 7
• Critical caveat: DAT can be negative in 48% of infants with serum antibodies and does not correlate well with severity of hemolytic disease 6
• Maternal blood group O with infant blood group A or B shows strongest association with positive DAT (OR: 15.7 for group A, 17.6 for group B) 7

Recommended Testing Approach

Standard Protocol

1. Perform ABO/RhD antigen typing on cord blood or within first 24 hours
2. Do NOT rely on reverse typing for blood group determination in infants under 6 months
3. Include DAT testing when mother is blood group O or when there is known maternal alloimmunization 7

Enhanced Methods

• Automated microcolumn gel systems show superior performance over tube methods for detecting weak antibodies in young infants, with higher detection rates and agglutination intensity 3
• Consider molecular genotyping (PCR-SSP) when discrepancies exist or for definitive typing, as it provides 100% accuracy 5

Important Pitfalls to Avoid

False Results:

• Bacterial infections can cause B-like antigens, creating false concordance between forward and reverse typing 5
• Maternal antibodies coating fetal red cells may interfere with antigen typing
• Weak subgroups of A or B may be missed with standard testing

Timing Issues:

• Testing performed too early may miss delayed antibody appearance
• Cord blood bilirubin is not diagnostic of hemolytic disease but moderately predictive of peak levels 6

Clinical Context:

• Infants discharged before 48 hours of age need close follow-up regardless of testing protocol, as clinically significant jaundice from ABO incompatibility typically manifests before 48 hours 8
• Positive DAT alone does not predict severity of hemolytic disease 6